Still, the drug is expected to be a modest revenue-generator for the company, with analyst Shibani Malhotra, of RBC Capital Markets, modeling sales of about $5 million in 2014 and $35 million by 2017 and noting that the company expects peak seals of about $150 million to $200 million

Analyst Shibani Malhotra, of RBC Capital Markets, seemed even more upbeat than Leerink's Gerberry, in a research report

Barrett said Xenoport hopes to obtain Tecfidera for a new arm in the final cohort of a multiple ascending dose study of XP23829, a BG-12 prodrug. (See BioWorld Today, March 28, 2013.) In a research note, RBC Capital Markets LLC analyst Michael Yee said the "big picture Bull case" is that Xenoport is inexpensive, with at a market cap of approximately $300 million and a reasonable chance of moving XP23829 to market in MS or psoriasis, perhaps partnered with a pharma company "to help speed and

Oxygen Biotherapeutics Inc., of Morrisville, N.C., said the Nasdaq Listing Qualifications Panel granted the company's request for continued listing on the Nasdaq Capital Market through June 3 to comply with the minimum $1 bid price requirement and through July 31 to comply with the minimum $2.5 million stockholders' equity requirement

Citigroup and Leerink Swann are servicing as joint book-running managers, while BMO Capital Markets is the lead manager and Robert W. Baird & Co

Receptos Inc., of San Diego, said it completed its initial public offering of 5.2 million shares priced at $14 apiece for proceeds of $72.8 million and granted underwriters Credit Suisse Securities LLC, Leerink Swann LLC, BMO Capital Markets and Wedbush PacGrow Life Sciences a 30-day option to purchase up to an additional 780,000 shares to cover overallotments...Rockwell also granted underwriters Chardan Capital Markets LLC, Summer Street Research Partners and C&Co/Prince Ridge LLC a 30-day option

On Friday, Shibani Malhotra, an analyst with RBC Capital Markets LLC, wrote that "Actavis management recently discussed its interest to lower its tax rate

The split is intended to increase the per-share trading price of the common stock to satisfy the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market...Trading of the company's common stock on the Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on May 13, under new CUSIP number 69207P308

capital markets, raise the company's profile in the U.S

BMO Capital Markets, Cowen and Co

Chardan Capital Markets LLC acted as exclusive placement agent for the offering.

It also will take the burden off the Pasadena, Calif.-based firm of having to "continually go to the capital markets for small rounds," he added

MLV & Co. $60 GW Pharma plc (Wilshire, UK; GWPH)4 3/19/13 3.5ADS $8.90 175.4 Lazard Capital Markets Cowen & Co. (co-lead) Canaccord Genuity Roth Capital Partners $31.15 Insys Therapeutics Inc. (Phoenix; INSY) 4/23/13 4S $8-$10 20.8 Wells Fargo Securities JMP Securities (co-lead) Oppenheimer & Co. $36 Kamada Ltd. (Ness Ziona, Israel; KMDA) 4/11/13 N/A N/A N/A Morgan Stanley Jefferies (co-lead) $69 Oncomed Pharmaceuticals Inc. (Redwood City, Calif.; OMED) 5/11/12 N/A N/A N/A Jefferies

AVEO's confidence in the drug was shared by RBC Capital Markets analyst Adnan Butt, who said he believes tivozanib "could be a differentiated agent that could demonstrate better efficacy than existing kidney cancer drugs

is higher than what it should be, Greifeld said, and there's a gap between that and the venture capital market

LONDON – After struggling to maintain momentum and keep going during the capital markets crisis, Verona Pharma plc's recently appointed CEO, Jan-Anders Karlsson, has managed to line up the financing needed to shape the company's two lead programs for partnering

LLC and BMO Capital Markets would act as joint book-running managers for the IPO, joined by co-managers Canaccord Genuity Inc., Needham & Co

RBC Capital Markets analysts Adnan Butt and Michael Yee said they think tivozanib could squeak through, but expect another study to be recommended

Similarly, Bravo declined to discuss in any detail how any trial would be financed, saying only that it could be from existing funds, alternative financing sources, soft loans, capital markets or partnering